Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Xiaoyu Zhang has a total of 23 co-authors. Here are the top co-authors by number of shared publications:

  • Hong Zhu

    Department of Rheumatology, General Hospital of Ningxia Medical University, Yinchuan, China

    2 shared publications
  • Ge Wang

    University of Health and Rehabilitation Sciences, Qingdao Municipal Hospital Group, Shandong, China

    1 shared publication
  • Jia Wang

    Biochip Center, General Hospital of Ningxia Medical University

    1 shared publication
  • Jian Zheng

    Department of Rheumatology, Zibo Central Hospital

    1 shared publication
  • Jing Li

    Guangdong Provincial Key Laboratory of Liver Disease Research, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China

    1 shared publication
  • Jinhai Tian

    Biochip Center, General Hospital of Ningxia Medical University, Ningxia, China

    1 shared publication

Latest Publications

  • Open Access

    Characteristics of peripheral blood neutrophil subsets in patients with primary Sjogren’s syndrome based on single-cell RNA sequencing

    by Zhaomeng Gao, Jian Zheng, Xueling Ma, Yuanwei Han, Jia Wang, Li Fang, Hong Zhu, Xiaoyu Zhang

    Background: Neutrophils, which are polymorphonuclear leukocytes of the phagocytic system, serve as critical mediators of inflammation-induced injury and are implicated in various diseases. However, the role of neutrophils in primary Sjögren’s syndrome (pSS) remains underexplored. Objectives: Single-cell RNA sequencing (scRNA-seq) was used to construct a map of neutrophil subsets and cell interactions in pSS, and to explore the roles and mechanisms of each subset in the development and progression of pSS, thereby providing new theoretical support for the pathogenesis of pSS and clinical drug development. Methods: Include newly diagnosed patients with pSS who presented to the Rheumatology and Immunology Department of Ningxia Medical University General Hospital between December 2022 and January 2025. Peripheral blood neutrophils were obtained from pSS and healthy control (HC) subjects. Following quality control, dimensionality reduction, clustering, and cell annotation, we analyzed compositional and distributional differences in neutrophil subsets between the pSS and HC groups. Significantly differentially expressed genes (DEGs) in neutrophils underwent Gene Ontology (GO) enrichment analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis, along with molecular interaction and pseudo-time analysis between cells. The DEGs LY6E and CLEC12A were further verified by RT-qPCR. Statistical analysis was performed using the non-paired two-tailed Wilcoxon rank-sum test, Mann-Whitney U test, and non-paired two-tailed Student’s t-test. Visualization was conducted using Monocle and CellphoneDB software. Results: Neutrophil counts were significantly lower in the pSS group compared to the HC group. Neutrophils were further clustered into six subsets (Neutrophil 1, Neutrophil 2, Neutrophil 3, Neutrophil 4, Neutrophil 5, and Neutrophil 6), with Neutrophil 2 exhibiting distinct characteristics. The DEGs in neutrophils were primarily involved in biological processes such as viral response and defense, type I interferon signaling pathways, and were enriched in signaling pathways including interferon-α response and inflammatory response. Neutrophils interact with natural killer (NK) cells and plasmacytoid dendritic cells (pDCs) via CCL5-CCR1, LGALS9-HAVCR2, FTH1-SCARA5, and FTL-SCARA5. Pseudo-time analysis revealed that neutrophils first differentiate into the Neutrophil 2 subset and ultimately into the Neutrophil 4 subset. This progression is characterized by progressively enhanced cellular signaling and behavioral regulation capabilities, while concurrently diminishing immune defense responses and neutrophil-mediated immune functions. Conclusion: Each subset of neutrophils is involved in the occurrence and development of pSS disease at different stages. In particular, LY6E and CLEC12A among the DEGs specifically upregulated by pSS neutrophils may be biomarkers and potential therapeutic targets for pSS.

  • Open Access

    The circular RNA hsa_circ_0045800 serves as a favorable biomarker in pathogenesis of sjögren's syndrome

    by Hong Zhu, Yi Wang, Ge Wang, Yitong Ling, Jinhai Tian, Yan Zhou, Rong Zhu, Rui Wang, Ruixin Wang, Wenhui Zhang, et al.

    Background: Circular RNAs (circRNAs) play various roles in the development of many autoimmune diseases. However, their expression profiles and specific function in Sjögren's Syndrome remains largely unknown. Objectives: We aimed to investigate circRNAs potential diagnostic value in primary Sjögren's syndrome (pSS) and contribution to the pathogenesis of pSS. Methods: This study included 102 subjects, 51 pSS patients and 51 healthy controls. The concentration of hsa_circ_0045800 was analyzed in peripheral blood mononuclear cells obtained from 51 pSS patients and 51 healthy controls by qRT-PCR. We established a receiver operating characteristic curve (ROC) to assess the biological diagnostic value of hsa_circ_0045800 for pSS. In addition, we analyzed the correlation between hsa_circ_0045800 and disease activity in Sjogren's syndrome. A differential analysis was also conducted on the concentration of hsa_circ_0045800 in patients in pSS patients before and after treatment. We studied the downstream mechanism of hsa_circ_0045800 through bioinformatics analysis and confirmed it using luciferase reporter gene assay. Results: We confirmed that the concentration of hsa_circ_0045800 was elevated 10.4-fold in peripheral blood mononuclear cells of pSS patients than in healthy controls (p = 0.00). In the pSS active disease group, the concentration of hsa_circ_0045800 is 2.5-fold higher compared to the pSS non-active disease group (p = 0.04). The concentration of hsa_circ_0045800 after treatment was decreased by 80% compared with that before treatment (p = 0.037), suggesting its utility as a potential marker for monitoring treatment efficacy. ROC curve analysis showed that the diagnostic value of hsa_circ_0045800 in pSS patients was significantly higher than that in healthy controls, with an area under the curve of 0.865, a sensitivity of 74%, and a specificity of 92%. The concentration of hsa_circ_0045800 is correlated with various clinical factors: the concentration of hsa_circ_0045800 is positively associated with age (r = 0.328, P = 0.019), oral dryness (r = 0.331, P = 0.017), while it is negatively correlated with HGB (r = -0.435, P = 0.001) and and hypothyroidism (r = -0.318, P = 0.023). Bioinformatics predictions and luciferase assays indicated that hsa_circ_0045800 acts as a molecular sponge for miR-1247-5p, with SMAD2 being a target gene of miR-1247-5p. Conclusion: Our study results show that hsa_circ_0045800 potentially contributes to the development and progression of pSS via the miR-1247-5p/SMAD2 pathway. Peripheral blood mononuclear cells are directly involved in the pathogenesis of pSS, and the discovery of hsa_circ_0045800 in peripheral blood mononuclear cells highlights its potential as a novel biomarker for disease activity and diagnosis in patients with pSS. Key Points• The concentration of hsa_circ_0045800 was higher in peripheral blood mononuclear cells of pSS patients.• Hsa_circ_0045800 promoted pSS progression through miR-1247-5p–SMAD2 axis.• Hsa_circ_0045800 is a potential biomarker for pSS.


  • Open Access

    Comprehensive Analysis of ANLN in Human Tumors: A Prognostic Biomarker Associated with Cancer Immunity

    by Xiaoyu Zhang, Lin Li, Shaozhuo Huang, Weixin Liao, Jing Li, Zexuan Huang, Yuehua Huang, Yifan Lian

    Background. Anillin (ANLN), a ubiquitously expressed actin‐binding protein, plays a critical tumor‐promoting role in cell growth, migration, and cytokinesis. Numerous studies have suggested that ANLN is upregulated in many cancer types, as well as significantly associated with patient prognosis and malignant cancer characteristics. Herein, we performed an integrated pan‐cancer analysis of ANLN and highlighted its underlying mechanism, which may benefit further exploration of the potential therapeutic options for cancer. Methods. ANLN expression data were extracted from online databases, including TCGA, GTEx, and CCLE databases. The TIMER database was used to study the association between ANLN expression with immune checkpoint genes and immunocyte infiltration. The ScanNeo pipeline was adopted for neoantigen discovery. KEGG analysis and the STRING tool were used to elucidate the potential mechanism of ANLN in cancer development. Results. ANLN is abnormally overexpressed in almost all cancer tissues compared with normal tissues. The high‐ANLN expression level was positively associated with various malignant characteristics, suggesting its potential role in the immune microenvironment and poor prognosis. In addition, ANLN expression was correlated with the number of neoantigens and different phosphorylation pattern in various cancer types, revealing a functional role of genetic mutation accumulation and high phosphorylation in ANLN‐mediated oncogenesis. Moreover, we found that ANLN was an important regulatory factor participating in many signaling events, especially the cell cycle and nucleocytoplasmic transport pathways. Conclusions. ANLN expression is generally overexpressed in various types of cancers, and it may have an important influence on tumor progression and development. ANLN expression is significantly associated with the immune checkpoint biomarkers and tumor immunity. Together, these findings suggest that ANLN may be a predictive marker for patient prognosis across cancers.